menu
    • menu

    Company profile for Endevica Bio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. The company was formed in 2009 to create best in class peptide drug candidates with better safety and efficacy properties than other drugs in the same class.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Endevica BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1601 S. Providence Rd. Columbia, MO 65211 USA
    Telephone
    Telephone
    (573) 881-5080
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://endevicabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Endevica Bio Starts Phase 2 Trial in Stage 4 Colorectal Cancer
    Endevica Bio Starts Phase 2 Trial in Stage 4 Colorectal Cancer

    17 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-announces-first-patient-dosing-in-phase-2-trial-in-patients-with-stage-4-metastatic-colorectal-cancer-302431924.html

    PR NEWSWIRE
    17 Apr 2025
    Share Share
    Endevica Bio to Start Ph 2 Trial for Weight Loss in Cancer Patients
    Endevica Bio to Start Ph 2 Trial for Weight Loss in Cancer Patients

    20 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-to-start-phase-2-clinical-trial-of-drug-to-prevent-weight-loss-in-cancer-patients-302336946.html

    PR NEWSWIRE
    20 Dec 2024
    Share Share
    Endevica Bio Spins Off New Company to Develop Weight Loss Drug
    Endevica Bio Spins Off New Company to Develop Weight Loss Drug

    01 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-spins-off-new-company-to-develop-weight-loss-drug-302294209.html

    PR NEWSWIRE
    01 Nov 2024
    Share Share
    Endevica Bio drug candidate shows success in weight loss in new study
    Endevica Bio drug candidate shows success in weight loss in new study

    23 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/endevica-bio-drug-candidate-shows-success-in-weight-loss-in-new-study-302124298.html

    PR NEWSWIRE
    23 Apr 2024
    Share Share
    Orbit and Endevica Enter Collaboration for Cachexia Therapeutics
    Orbit and Endevica Enter Collaboration for Cachexia Therapeutics

    01 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230201005470/en

    BUSINESSWIRE
    01 Feb 2023
    Share Share
    Endevica Reports Positive TCMCB07 Data from Phase 1 Trial in Cachexia
    Endevica Reports Positive TCMCB07 Data from Phase 1 Trial in Cachexia

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005707/en

    BUSINESSWIRE
    15 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search